Johnson & Johnson, like all drug makers in the COVID-19 vaccine race, hopes to muster enough manufacturing capacity to rapidly scale production of its vaccine. Now, for a sum of nearly half a trillion dollars, J&J is ready to put his money where his mouth is. J&J and Maryland-based CDMO …
Read More »J&J sews 5-year supply of coronavirus vaccine in more than $ 480 million deal with Emergent
